Posted on
19 Feb
2019
News of interest to medical writers: Big Data
Recommendations for a path towards understanding the acceptability of evidence derived from ‘Big Data’ in support of the evaluation and supervision of medicines by regulators have been published as part of a summary report of the Heads of Medicines Agencies (HMA) - EMA Joint Big Data task force.
Read the report here.